Evolving therapeutic strategies for acromegaly.
Darzy
K H
KH
Department of Endocrinology, Christie Hospital, Manchester, UK. Ken.Darzy@Christie-TR.Nwest.NHS.UK
Shalet
S M
SM
D000172:Acromegaly / Q000209:etiology / Q000628:therapy*; D000236:Adenoma / Q000378:metabolism / Q000601:surgery / Q000628:therapy; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D006727:Hormone Antagonists / Q000627:therapeutic use; D019382:Human Growth Hormone / Q000378:metabolism; D006801:Humans; D010911:Pituitary Neoplasms / Q000378:metabolism / Q000601:surgery / Q000628:therapy; D011878:Radiotherapy
D000970:Antineoplastic Agents; D006727:Hormone Antagonists; D019382:Human Growth Hormone